Genupharm Pioglitazone Tablets (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Genupharm Co., Ltd.
MFDS item code 202004516 · Approved 2020.06.22
This product's status changed to Expired on 2025.06.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improves blood glucose control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used as monotherapy, or when blood sugar improvement is inadequate with other oral hypoglycemics, it is administered in combination with sulfonylureas, metformin, or insulin. Additionally, patients with type 2 diabetes require nutritional counseling, weight loss, and regular exercise. These efforts are critical not only for initial treatment but also for maintaining the effectiveness of pharmacotherapy. This medication is effective in improving blood sugar control.
This medicine is taken orally once daily, regardless of meals. Monotherapy may be started at 15 mg once daily; if the effect is insufficient, the dose may be increased to 30 mg once daily. For combination therapy with a sulfonylurea, metformin, or insulin, administer 15 mg once daily. The maximum recommended dose is 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.
This medication is used for the treatment of type 2 diabetes. It may cause or worsen congestive heart failure in some patients, so when starting treatment or increasing the dose, symptoms of heart failure such as rapid weight gain, shortness of breath, and leg swelling should be carefully monitored. It is advisable to avoid this medication in patients with heart failure, and if symptoms of heart failure occur, medical consultation should be sought immediately. When administered with insulin, this medication may lead to fluid retention, increasing the risk of heart failure, so caution is required in such cases. This medication should not be used in patients with a history of bladder cancer or active bladder cancer, and if hematuria or urinary disorders occur during treatment, healthcare providers should be notified immediately. Patients with impaired liver function or severe renal impairment should also use this medication with caution. When used in conjunction with other diabetes medications that pose a risk of hypoglycemia, symptoms of hypoglycemia may occur, so understanding hypoglycemia symptoms and management is essential. Side effects such as edema, weight gain, headaches, upper respiratory infections, myalgia, may occur, and if abnormal symptoms persist, consultation with a doctor is necessary. Women who are pregnant or may become pregnant must consult a healthcare provider before taking this medication, and special caution is required for nursing mothers. This medication is not recommended for children and adolescents under 18 years of age, as safety and efficacy have not been established. Elderly patients should be closely monitored during administration, especially those aged 75 years and older. Regular monitoring of blood glucose and liver function tests is required while taking this medication, and any sudden weight gain or symptoms of edema or shortness of breath should be reported to a physician immediately. Finally, this medication should be stored out of reach of children, and kept in its original container to maintain quality.
Congestive heart failure, excessive and rapid weight changes, shortness of breath, swelling, fluid retention, inadequate blood sugar control, upper respiratory tract infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, worsening of congestive heart failure, emergency room visits due to congestive heart failure, progression of congestive heart failure, adverse reactions related to edema, decrease in hemoglobin, elevation of serum ALT levels, liver failure, diabetic macular edema accompanied by vision reduction, bladder cancer, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle rigidity, head discomfort, increased liver enzymes, worsening of liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness syndrome, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simplex herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, cardiac failure, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that can block light and air, and should be kept away from humid places. The ideal storage temperature is between 15 and 30 degrees Celsius, and it is advisable to store it at room temperature around 25 degrees Celsius.
White round tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.